When was Cayman Chem founded?

Cayman Chem was founded in 1980 and raised its 1st funding round 37 years after it was founded.

Where is Cayman Chem located?

Cayman Chem is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan.

How many employees does Cayman Chem have?

As of Apr 30, 2026, the latest employee count at Cayman Chem is 264.

Is Cayman Chem a funded company?

Cayman Chem is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 30, 2017.

When was the latest funding round of Cayman Chem?

Cayman Chem's latest funding was a $***** Grant (prize money) round on Jun 24, 2025, with participation from 1 investor.

Where does Cayman Chem rank among its competitors?

Cayman Chem ranks 3rd amongst 89 active competitors, of which 13 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Genoskin, which secured $5.4M in Sep, 2025.

Who are the top competitors of Cayman Chem?

Cayman Chem's top competitors include Magnitude Biosciences, Genoskin and Reaction Biology. Among them, Genoskin secured the most recent funding round in September, 2025.

Cayman Chem - 2026 Company Profile, Funding & Competitors

Company Details

Cayman Chem develops kits and reagents for research application. The product portfolio of the company includes antibodies, assay kits, biochemicals, and proteins.And, it offers services in the following category bioanalytical, custom antibody, bioenergetics, organic synthesis, epigenetic screening and profiling, protein production and purification, and medicinal chemistry. In addition to this, it offers API and forensic services.Their service portfolio includes chemical synthesis, chemical analysis, bioanalysis, medicinal chemistry at the preclinical stage and API development and manufacturing services.

Website: www.caymanchem.com/
Social
Email ID: *****@caymanchem.com
Registered Address: Ann Arbor, Michigan

Key Metrics

Founded Year

1980

Location

Ann Arbor, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Jun 24, 2025, $*****

Investors

Broadoak Capital Partners & 3 more

Ranked

3^rd among 89 active competitors

Employee Count

264 as on Apr 30, 2026

Investment & Acquisitions

Matreya

Similar Companies

Magnitude Biosciences & 98 more

View Cayman Chem's full profile

Cayman Chem is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cayman Chemical Company, Inc. CIN: 840845784 , United States, Active	Dec 26, 999	-	333 (As on Dec 31, 2024)	-

Cayman Chem has raised funding over 6 rounds. Its first funding round was on Sep 30, 2017. Its latest funding round was a Grant (prize money) round on Jun 24, 2025 for $*****. 1 investor participated in its latest round. Cayman Chem has 4 institutional investors.

Here is the list of recent funding rounds of Cayman Chem:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 24, 2025	8342155	Grant (prize money)	7550231	3939606	3359839	6741804
Apr 08, 2025	9052233	Grant (prize money)	2385381	8640033	9492969	HHS
Sep 23, 2021	3994284	Grant (prize money)	5636402	2371063	2949690	NIDCR

Access funding benchmarks and valuations. Sign up today!

View details of Cayman Chem's funding rounds and investors

Cayman Chem's employee count trend

Cayman Chem has 264 employees as of Apr 26. Here is Cayman Chem's employee count trend over the years:

Uncover Cayman Chem's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cayman Chem include Magnitude Biosciences, Genoskin and Reaction Biology. Here is the list of Top 10 competitors of Cayman Chem, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Magnitude Biosciences 2018, Durham (United Kingdom), Seed	Provider of cell-free in vitro assay for drug discovery companies	$2.6M	Northstar Ventures, Saker Capital & 10 others	58/100
2nd	Genoskin 2011, Toulouse (France), Series A	In vitro human skin models for preclinical toxicity and efficacy testing	$5.4M	OCCTE, Caisse D Epargne & 7 others	54/100
3rd	Cayman Chem 1980, Ann Arbor (United States), Funding Raised	Develops bioreagents and offers preclinical services	-	Broadoak Capital Partners, HHS & 2 others	50/100
4th	Reaction Biology 2001, United States, Late Stage	In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling	-	Cobepa, National Cancer Institute & 6 others	45/100
5th	ACE Research 2016, Kisumu (Kenya), Unfunded	Provider of contract research organization services for clinical trials	-	-	43/100
6th	Radiant Research Services 2009, Bengaluru (India), Acquired	Preclinical in vitro testing and development services	-	-	39/100
7th	Discovery Biomed 2007, Birmingham (United Kingdom), Acquired	Contract research organization	-	NIDDK, NIH & 4 others	39/100
8th	Quantumcyte 2013, Sunnyvale (United States), Seed	Drug assay system to treat cancer	$1.3M	IndieBio, Bayes Ventures	39/100
9th	Syntax Bio 2018, Chicago (United States), Unfunded	Preclinical-stage biotech company that develops innovative stem cell-derived therapies by leveraging CRISPR technology	-	-	35/100
10th	Leadgene Biomedical 2013, Tainan (Taiwan), Unfunded	CRO offers invitro drug testing services	-	-	35/100